000			02090 a2200625 4500
005			20250515075519.0
264		0	_c20071130
008			200711s 0 0 eng d
022			_a0270-9139
024	7		_a10.1002/hep.21791 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchaefer, Martin
245	0	0	_aHepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. _h[electronic resource]
260			_bHepatology (Baltimore, Md.) _cOct 2007
300			_a991-8 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAntidepressive Agents _xtherapeutic use
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aDepression _xchemically induced
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadverse effects
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMental Disorders _xcomplications
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aSubstance-Related Disorders _xcomplications
650	0	4	_aTreatment Outcome
700	1		_aHinzpeter, Axel
700	1		_aMohmand, Ariane
700	1		_aJanssen, Gesa
700	1		_aPich, Maurice
700	1		_aSchwaiger, Markus
700	1		_aSarkar, Rahul
700	1		_aFriebe, Astrid
700	1		_aHeinz, Andreas
700	1		_aKluschke, Michael
700	1		_aZiemer, Marlene
700	1		_aGutsche, Juri
700	1		_aWeich, Viola
700	1		_aHalangk, Juliane
700	1		_aBerg, Thomas
773	0		_tHepatology (Baltimore, Md.) _gvol. 46 _gno. 4 _gp. 991-8
856	4	0	_uhttps://doi.org/10.1002/hep.21791 _zAvailable from publisher's website
999			_c17201702 _d17201702